NCT01839604 - A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions

Advanced Adult Hepatocellular CarcinomaHepatocellular Carcinoma Metastatic

Interventions

DRUG

AZD9150

Intravenous infusion over 3 hours.

Trial Locations (7)

Research Site, Hong Kong

Research Site, Chūōku

Research Site, Kashiwa-shi

Research Site, Matsuyama

Research Site, Seoul

Research Site, Tainan City

Research Site, Taipei